Kymera Therapeutics KYMR Contract Assets
Contract Assets at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetNetCurrent.
The official record: Kymera Therapeutics’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's contract assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's contract assets?
- Kymera Therapeutics (KYMR) reported contract assets of $0 in Q3 2025.
- How has Kymera Therapeutics's contract assets changed year-over-year?
- Kymera Therapeutics's contract assets decreased by 100.0% year-over-year, from $1.32M to $0.
- What is the long-term trend for Kymera Therapeutics's contract assets?
- Over 4 years (2020 to 2024), Kymera Therapeutics's contract assets has grown at a 2.6% compound annual growth rate (CAGR), from $856K to $947K.
- What does contract assets mean?
- Revenue recognized under ASC 606 where the right to payment is conditional on something other than the passage of time — work performed but not yet billable.